相似文献
1
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.
J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11.
2
Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.
Clin Vaccine Immunol. 2014 Mar;21(3):391-8. doi: 10.1128/CVI.00748-13. Epub 2014 Jan 8.
3
Assessment of sensitivity and specificity of first, second, and third generation EIA for the detection of antibodies to HIV-1 in oral fluid.
J Virol Methods. 2009 Jul;159(1):119-21. doi: 10.1016/j.jviromet.2009.02.016. Epub 2009 Feb 24.
4
Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.
J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):304-12. doi: 10.1097/01.qai.0000242465.50947.5f.
5
Identifying the early post-HIV antibody seroconversion period.
J Infect Dis. 2011 Aug 15;204(4):526-33. doi: 10.1093/infdis/jir304.
6
7
Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
Transfusion. 1996 Jan;36(1):37-44. doi: 10.1046/j.1537-2995.1996.36196190513.x.
8
Evaluation of epidemiological and serological predictors of human immunodeficiency virus type-1 (HIV-1) infection among high risk professional blood donors with western blot indeterminate results.
J Clin Virol. 1998 Jul 24;11(1):39-49. doi: 10.1016/s0928-0197(98)00041-5.
9
Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.
AIDS Res Hum Retroviruses. 2010 Jan;26(1):61-71. doi: 10.1089/aid.2009.0133.
10
Use of laboratory tests and clinical symptoms for identification of primary HIV infection.
AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005.
引用本文的文献
1
Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity.
Microbiol Spectr. 2023 Jun 15;11(3):e0071523. doi: 10.1128/spectrum.00715-23. Epub 2023 May 24.
2
Detection of porcine cytomegalovirus, a roseolovirus, in pig ovaries and follicular fluid: implications for somatic cells nuclear transfer, cloning and xenotransplantation.
Virol J. 2023 Jan 27;20(1):15. doi: 10.1186/s12985-023-01975-7.
3
The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update.
J Womens Health (Larchmt). 2016 Mar;25(3):222-34. doi: 10.1089/jwh.2015.5671. Epub 2016 Feb 12.
4
HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians.
Vaccine. 2015 Mar 3;33(10):1243-9. doi: 10.1016/j.vaccine.2014.10.040. Epub 2015 Jan 31.
5
H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.
J Virol. 2011 Dec;85(23):12455-63. doi: 10.1128/JVI.06023-11. Epub 2011 Sep 28.
本文引用的文献
1
Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.
PLoS Pathog. 2009 Jan;5(1):e1000274. doi: 10.1371/journal.ppat.1000274. Epub 2009 Jan 23.
2
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
J Virol. 2008 Dec;82(24):12449-63. doi: 10.1128/JVI.01708-08. Epub 2008 Oct 8.
3
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.
J Virol. 2007 Jun;81(12):6187-96. doi: 10.1128/JVI.00239-07. Epub 2007 Apr 4.
4
Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.
J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):304-12. doi: 10.1097/01.qai.0000242465.50947.5f.
5
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.
J Virol. 2006 Mar;80(5):2092-9. doi: 10.1128/JVI.80.5.2092-2099.2006.
6
Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.
AIDS. 2004 Aug 20;18(12):1697-705. doi: 10.1097/01.aids.0000131395.14339.f5.
7
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.
AIDS. 2003 Sep 5;17(13):1871-9. doi: 10.1097/00002030-200309050-00005.
8
Gender difference in HIV RNA levels: a meta-analysis of published studies.
J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):11-9. doi: 10.1097/00126334-200209010-00002.
9
Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus.
Clin Infect Dis. 2002 Feb 15;34(4):529-34. doi: 10.1086/338397. Epub 2002 Jan 9.
10
Rapid HIV testing and counseling for voluntary testing centers in Africa.
AIDS. 1997 Sep;11 Suppl 1:S103-10.
Zotero 插件